KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Notes Payables (2016 - 2017)

Teva Pharmaceutical Industries filings provide 7 years of Notes Payables readings, the most recent being $1.0 million for Q4 2017.

  • On a quarterly basis, Notes Payables fell 93.33% to $1.0 million in Q4 2017 year-over-year; TTM through Dec 2017 was $1.0 million, a 93.33% decrease, with the full-year FY2017 number at $1.0 million, down 93.33% from a year prior.
  • Notes Payables hit $1.0 million in Q4 2017 for Teva Pharmaceutical Industries, down from $15.0 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $75.0 million in Q4 2015 to a low of $1.0 million in Q4 2017.
  • Median Notes Payables over the past 4 years was $30.5 million (2014), compared with a mean of $34.2 million.
  • Biggest five-year swings in Notes Payables: skyrocketed 63.04% in 2015 and later crashed 93.33% in 2017.
  • Teva Pharmaceutical Industries' Notes Payables stood at $46.0 million in 2014, then skyrocketed by 63.04% to $75.0 million in 2015, then crashed by 80.0% to $15.0 million in 2016, then crashed by 93.33% to $1.0 million in 2017.
  • The last three reported values for Notes Payables were $1.0 million (Q4 2017), $15.0 million (Q4 2016), and $75.0 million (Q4 2015) per Business Quant data.